Community-Based Distribution of Misoprostol for the Prevention of ...
Community-Based Distribution of Misoprostol for the Prevention of ...
Community-Based Distribution of Misoprostol for the Prevention of ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
INFORMED CONSENT (VERBAL)<br />
(INSTRUCTIONS FOR THE MODERATOR: All <strong>of</strong> <strong>the</strong> field workers who will be contacted about participating<br />
in <strong>the</strong> FGD will be asked to give <strong>the</strong>ir in<strong>for</strong>med consent, using <strong>the</strong> following standardized statement. Please<br />
read <strong>the</strong> following statement be<strong>for</strong>e starting FGD.)<br />
(Greet <strong>the</strong> person—Hello/Salam/Aasalaamu Aleikum). My name is .........................……. I am with <strong>the</strong> Mayer<br />
Hashi project <strong>of</strong> EngenderHealth, an international NGO. I hope you know that a pilot project on misoprostol<br />
use during home delivery to prevent postdelivery excessive vaginal bleeding has been implemented at eight<br />
upazilas <strong>of</strong> Tangail District during <strong>the</strong> period <strong>of</strong> November 2008-June 2009, by EngenderHealth in<br />
collaboration with <strong>the</strong> Directorate General <strong>of</strong> Health Services and Directorate General <strong>of</strong> Family Planning. We<br />
are conducting a study to understand why some women have taken <strong>the</strong> misoprostol drug immediately after<br />
delivery <strong>of</strong> <strong>the</strong>ir baby and why some women did not take it. Also, we would like to know individuals’ opinions<br />
and suggestions about <strong>the</strong> distribution and follow-up system <strong>of</strong> misoprostol tablets at <strong>the</strong> community levels.<br />
Findings <strong>of</strong> this study will help <strong>the</strong> government make policy decisions to reduce maternal deaths and to achieve<br />
MDG 5 in Bangladesh.<br />
As a part <strong>of</strong> this study, we would like to conduct a small group discussion with all <strong>of</strong> you to know your opinions,<br />
experience, and suggestions. This small group will consist <strong>of</strong> 7-10 persons. The discussion will continue <strong>for</strong> one<br />
and one-half hours. The risk <strong>of</strong> your participation in this study is minimal. Your participation in this interview is<br />
completely voluntary and you will not be penalized if you decide not to participate or refuse to respond to any<br />
question; you can even keep silent. You will not receive any direct benefit or money <strong>for</strong> your participation in<br />
<strong>the</strong> discussion. Your responses will be kept confidential. We will not share your in<strong>for</strong>mation with anyone, nor<br />
will we identify you in any way when <strong>the</strong> study findings are published. If you permit, <strong>the</strong> discussion between<br />
you and me will be tape recorded with voices only, to help us recall what has been discussed when preparing<br />
<strong>the</strong> report. Only <strong>the</strong> researchers will have access to your responses, which <strong>the</strong>y will utilize to prepare <strong>the</strong><br />
report.<br />
You may ask any questions or clarifications be<strong>for</strong>e giving your consent <strong>for</strong> FGD. You may also contact Dr.<br />
Halim (01712094176) or Mr. Mahboob (8112334/36) with any questions be<strong>for</strong>e or after <strong>the</strong> FGD.<br />
Do you have any questions? Yes _____ No_____<br />
If you do not have any questions, do I have your permission to continue? Yes _____ No_____<br />
Moderator’s Statement<br />
I, <strong>the</strong> undersigned, have explained <strong>the</strong> consent <strong>for</strong>m to <strong>the</strong> FGD participants in a language s/he understands.<br />
S/he has given her/his consent to conduct <strong>the</strong> FGD and has fully agreed to participate in <strong>the</strong> FGD.<br />
_________________________________<br />
Signature <strong>of</strong> Moderator<br />
___________________<br />
Date<br />
50 <strong>Community</strong>-<strong>Based</strong> <strong>Distribution</strong> <strong>of</strong> <strong>Misoprostol</strong> <strong>for</strong> <strong>the</strong> <strong>Prevention</strong> <strong>of</strong> PPH<br />
Mayer Hashi project